Abstract:Tumor-draining lymph nodes (TDLNs) are the first organs where the metastatic spread of different types of cancer, including head and neck cancer (HNC), occurs and have therefore high prognostic relevance. Moreover, first anti-cancer immune responses have been shown to be initiated in such LNs via tumor-educated myeloid cells. Among myeloid cells present in TDLNs, neutrophils represent a valuable population and considerably participate in the activation of effector lymphocytes there. Tumor-supportive or tumor-inhibiting activity of neutrophils strongly depends on the surrounding microenvironment. Thus, type I interferon (IFN) availability has been shown to prime anti-tumor activity of these cells. In accordance, mice deficient in type I IFNs show elevated tumor growth and metastatic spread, accompanied by the pro-tumoral neutrophil bias. To reveal the mechanism responsible for this phenomenon, we have studied here the influence of defective type I IFN signaling on the immunoregulatory activity of neutrophils in TDLNs. Live imaging of such LNs was performed using two-photon microscopy in a transplantable murine HNC model. CatchupIVM-red and Ifnar1-/- (type I IFN receptor- deficient) CatchupIVM-red mice were used to visualize neutrophils and to assess their interaction with T-cells in vivo. We have evaluated spatiotemporal patterns of neutrophil/T-cell interactions in LNs in the context of type I interferon receptor (IFNAR1) availability in tumor-free and tumor-bearing animals. Moreover, phenotypic and functional analyses were performed to further characterize the mechanisms regulating neutrophil immunoregulatory capacity. We demonstrated that inactive IFNAR1 leads to elevated accumulation of neutrophils in TDLNs. However, these neutrophils show significantly impaired capacity to interact with and to stimulate T-cells. As a result, a significant reduction of contacts between neutrophils and T lymphocytes is observed, with further impairment of T-cell proliferation and activation. This possibly contributes to the enhanced tumor growth in Ifnar1-/- mice. In agreement with this, IFNAR1-independent activation of downstream IFN signaling using IFN-λ improved the immunostimulatory capacity of neutrophils in TDLNs and contributed to the suppression of tumor growth. Our results suggest that functional type I IFN signaling is essential for neutrophil immunostimulatory capacity and that stimulation of this signaling may provide a therapeutic opportunity in head and neck cancer patients.

Type I IFNs Drive Hematopoietic Stem and Progenitor Cell Collapse Via Impaired Proliferation and Increased RIPK1-dependent Cell Death During Shock-Like Ehrlichial Infection.

Type I Interferons Promote Severe Disease in a Mouse Model of Lethal Ehrlichiosis

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Noncanonical NF-κB Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity

Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice

Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity

Type 1 interferon perturbates clonal competition by reshaping human blood development

Downregulation of the IFNAR1 Chain of Type 1 Interferon Receptor Contributes to the Maintenance of the Haematopoietic Stem Cells

Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency

Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons

An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation

Type I interferons in infectious disease

MyD88 Signaling in CD4 T Cells Promotes IFN-γ Production and Hematopoietic Progenitor Cell Expansion in Response to Intracellular Bacterial Infection

Type I Interferons Suppress Viral Replication but Contribute to T Cell Depletion and Dysfunction During Chronic HIV-1 Infection

Irgm1 Protects Hematopoietic Stem Cells by Negative Regulation of Ifn Signaling

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during infection

Molecular mechanism of RIPK1 and caspase-8 in homeostatic type I interferon production and regulation

Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway

IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph Nodes

Type I Interferons and Il-12: Convergence and Cross Regulation among Mediators of Cellular Immunity.